Compounds > calpeptin
Page last updated: 2024-08-25

calpeptin and Ambulation Disorders, Neurologic

calpeptin has been researched along with Ambulation Disorders, Neurologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banik, NL; Cox, AA; Haque, A; Knaryan, VH; Samantaray, S; Shields, DC1
E, M; Li, G; Wang, S; Wei, X; Yan, F; Yang, X; Yu, S; Zhang, C; Zhang, F1

Other Studies

2 other study(ies) available for calpeptin and Ambulation Disorders, Neurologic

ArticleYear
Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.
    Molecular neurobiology, 2015, Volume: 52, Issue:2

    Topics: Animals; Astrocytes; Calpain; Dipeptides; Dopaminergic Neurons; Gait Disorders, Neurologic; Inflammation; Lymphocyte Subsets; Macrophages; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Nerve Tissue Proteins; Parkinsonian Disorders; Spinal Cord; Substantia Nigra

2015
Neuroprotective Effect of Calpeptin on Acrylamide-Induced Neuropathy in Rats.
    Neurochemical research, 2015, Volume: 40, Issue:11

    Topics: Acrylamide; Animals; Behavior, Animal; Calpain; Cysteine Proteinase Inhibitors; Dipeptides; Female; Gait Disorders, Neurologic; Injections, Intraperitoneal; Neurofilament Proteins; Neuroprotective Agents; Neurotoxicity Syndromes; Rats; Rats, Wistar; Spinal Cord

2015